Shilpa Medicare launches pediatric dose Paracetamol Oral Thin Film

22 Jun 2021 Evaluate

Shilpa Medicare has launched first time in the world Oral Thin Film formulation, a pediatric dose Paracetamol Oral Thin Film, under the Brand name Molshil. Shilpa received approval for Molshil Oral Thin Films after sufficiently complying bioequivalence requirements. Shilpa's Paracetamol Oral Thin Films are patent protected and are first of this kind in the world.Shilpa has manufacturing facilities for paracetamol at both Hyderabad and Bangalore. The company has launched Paracetamol Oral Thin Films as 60 mg and 120 mg strengths in Orange Flavor.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

294.20 -0.85 (-0.29%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×